EU CRR definition

EU CRR means Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013, as supplemented by Commission Delegated Regulation (EU) No. 625/2014.
Sample 1Sample 2Sample 3
EU CRR means Regulation (EU) 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms, and amending Regulation (EU) No 648/2012, as amended.
Sample 1Sample 2Sample 3

Examples of EU CRR in a sentence

  • An exempt IFPRU commodities firm is subject to the non-capital requirements of IFPRU and the EU CRR.

  • The Information has been prepared to meet the requirements of the EU CRR regarding the disclosures of matters in Part 8 of the CRR.

  • EU CRR, Alternative Investment Fund Managers Directive, Solvency II Directive and UCITS Directive: risk retention and due diligence requirementsRisk retention and due diligence provisions require relevant investors to determine whether a retention arrangement is compliant and whether sufficient information is available for the requisite due diligence to be undertaken, thereby creating regulatory exposure for investors.

  • As EU CRR permits the exercise of certain national discretion, the implementation may be subject to some level of national variation.

  • Journal of General Internal Medicine 13(3), 151–54.Gneezy, Uri (2005) Deception: The role of consequences.

  • A firm required to report FINREP is either: a credit institution or investment firm subject to the EU CRR that is also subject to Article 4 of Regulation (EC) No 1606/2002, ora credit institution other than one referred to in Article 4 of Regulation (EC) No 1606/2002 that prepares its consolidated accounts in conformity with the international accounting standards adopted in accordance with the procedure laid down in Article 6(2) of that Regulation.This is a requirement under IFPRU 1.5.1R.

  • Some remaining EU CRR II provisions will apply in the EU from 28 June 2021.

  • However, IFPRU 2.2 (Internal capital adequacy assessment process) and IFPRU 2.3(Supervisory review and evaluation process: Internal capital adequacy standards) apply to the whole of its business.Purpose1.1.4G(1)The purpose of IFPRU is to implement, in part, CRD and certain national discretions afforded to the FCA as competent authority under EU CRR.

  • The EU CRR and EU CRD IV were a major EU legislative package that intended to address issues arising from the global financial crisis of 2008/9 following publication of the Basel III standards.

  • State budget division; cooperation with legislature and committees; to supply information to legislature and committees.

Related to EU CRR

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 1 Clinical Trial means, as to a specific Licensed Product or Licensed Service, a study as described in 21 C.F.R. §312.21(a) or a comparable clinical study in a country other than the United States.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • EU means the European Union.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.